Drugs / DS-1471a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06074705 | Aug 2023 → Jul 2025 | neoplasm | Daiichi Sankyo | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS-1471a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06074705 ↗ |
| Route | Intravenous | “Participants with locally advanced or metastatic tumors will receive intravenous DS-1471a.” NCT06074705 ↗ |